Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort ...
First, let’s look at what gets you there to begin with. “Doc, I pivoted, and my knee gave way.” Or “Doc, I hyperextended my knee and heard a pop.” Those, and a host of ...
Digital Signal Processor Market growth is driven by rising AI/ML workloads, demand for real-time audio/video processing, 5G expansion, automotive ADAS, and increasing use in consumer ...
West Virginia lawmakers are entering the 2026 legislative session hoping to make improvements to the state's overwhelmed ...
6 天on MSNOpinion
Chinese scientists messing with coronavirus create terrifying 'explosive diarrhoea' virus
Swine acute diarrhoea syndrome coronavirus has the potential to spill over to humans and animals, researchers say.
"The Founders chose this name to signal our strength and resolve to the world," the order declared. "The name 'Department of ...
"My biggest advice is to find great partners to build with. Starting a firm is incredibly challenging and requires a ...
Enstarz on MSN
Taylor Thomson on why electronic music's future belongs to storytellers, not specialists
DJs built reputations by mastering specific sounds, and audiences knew exactly what to expect when walking into a deep house night versus a hard techno rave. But in 2025, a growing movement of artists ...
Over the last decade, the number of cell and gene therapy clinical trials has more than tripled. In this article, several ...
To address this, Thermo Fisher Scientific now offers Accelerator Drug Development: a suite of integrated services combining CDMO and CRO capabilities to streamline the drug development journey, from ...
Today, U.S. Senator Rand Paul, Chairman of the Senate Homeland Security and Governmental Affairs Committee, convened a hearing to discuss a newreportexposing the Federal Reserve's use of Interest on ...
Opinion
Outlook Business on MSNOpinion
Don't Ask for ₹100 Cr, Ask for ₹3 Cr: Why This Expert Wants Deep Tech Cos to Take One ...
India’s deep-tech journey needs smarter funding, stronger R&D and industry–academia collaboration. FSID’s Yogesh Pandit explains the gaps and the path to 2047 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果